Open Orphan (ORPH) presents an opportunity to invest in a companytargeting value creation and rapid scale-up via acquisitions in the orphan and rare drugs market, which is growing at around 11% a year, around twice as fast as the global pharmaceuticals market. At the same time, there is a great dis
08 Aug 2019
Open Orphan: creating a valuable niche
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Open Orphan: creating a valuable niche
hVIVO plc (HVO:LON) | 29.0 0 0.3% | Mkt Cap: 197.3m
- Published:
08 Aug 2019 -
Author:
Emma Ulker -
Pages:
15
Open Orphan (ORPH) presents an opportunity to invest in a companytargeting value creation and rapid scale-up via acquisitions in the orphan and rare drugs market, which is growing at around 11% a year, around twice as fast as the global pharmaceuticals market. At the same time, there is a great dis